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Summary 
Interleukin 4 (IL-4) induces immunoglobulin (Ig)E and IgG4 synthesis in human B cells. In 
addition to IL-4, costimulatory signals provided by activated  CD4 + T  cells are required for 
productive IgG4 and IgE synthesis. Here we report that the 26-kD transmembrane form of tumor 
necrosis factor c~ (mTNF-ol), which is rapidly expressed on CD4 + T cell dones after activation, 
contributes to the costimulatory signals resulting in IL-4-dependent Ig synthesis by B cells, including 
IgG4 and IgE production, mTNF-cz expression was induced on T cell clones within 2 h after 
activation with concanavalin A. Peak expression was observed at 24 h, followed by a gradual 
decrease, but appreciable levels of mTNF-c~ were still detectable 72 h after activation. The presence 
of the 26-kD membrane form of TNF-c~ on activated T cell clones was confirmed by immuno- 
precipitation. Monoclonal antibodies (mAbs) recognizing mTNF-o~, or the p55 TNF receptor, 
inhibited IgM, IgG, IgG4, and IgE synthesis induced by IL-4 and activated CD4 + T cell clones 
in cultures of highly purified surface IgD + B cells. The anti-TNF-c~  mAbs also blocked Ig 
production in cultures in which the activated CD4 + T cell clones were replaced by their plasma 
membranes. Furthermore, pretreatment of the plasma membranes with anti-TNF-ol mAbs strongly 
reduced their capacity to stimulate B cells to produce Ig in the presence of IL-4, indicating that 
the anti-TNF-o~ mAbs blocked the effects of mTNF-o~. Anti-TNF-c~ mAbs did not affect IgM, 
IgG, IgG4, or IgE synthesis induced by anti-CD40 mAbs and IL-4 in the absence of CD4 + 
T cells, supporting the notion that the anti-TNF-ot mAbs indeed interfered with the costimulatory, 
contact-mediated signal provided by T cells, or their membranes. Collectively these results indicate 
that mTNF-ol, which is rapidly induced after activation of CD4 + T  cells, participates  in pro- 
ductive T-B cell interactions resulting in IL-4-induced Ig production. This is a novel property 
of the T  cell membrane form of TNF-a. 
T 
he requirement of IL-4 for IgE production has been es- 
tablished in both mice (1)  and humans (2).  Previous 
studies have shown that addition of IL-4 to human PBMC 
results in IgE production (2). However, IL-4 fails to induce 
IgE synthesis by highly purified B cells (2, 3), although it 
induces germline e transcription (4, 5). In addition to IL-4, 
contact-mediated costimulatory signals are necessary for the 
induction of IgE synthesis by B cells (2, 6-9). It has been 
shown that these costimulatory signals can be provided by 
activated CD4 +  , TCR oJ3 + , or TCR "y/~+ T cell clones 
by direct T-B cell contacts (7, 8, 10). Plasma membranes pre- 
pared from activated CD4 + T cell clones can replace intact 
T cells in delivering this costimulatory signal in both human 
(6)  and  murine systems  (11) irrespective  of whether the 
CD4 § T  cells are of the Thl or Th2 type (12). Alterna- 
tively,  the second signal required for IgE synthesis can be 
provided by mAbs to the CD40 antigen on B cells (13-15), 
by hydrocortisone treatment (16) or through EBV infection 
of B cells (17). 
Engagement of the CD40 molecule results in B cell acti- 
vation, and recently the murine (18) and human (19-21) ligands 
for CD40  (CD40L), 1 have been cloned. Both the human 
and mouse CD40L,  when expressed  on  CV1/EBNA  or 
COS-7 cells, induce proliferation and IL-4-dependent IgE syn- 
thesis by human and murine B cells (18-21). The CD40L is 
expressed  as an early  activation antigen by CD4 + T  cell 
dones (18, 19, 21) as well as by CD8 + clones (19, 21). Thus, 
triggering B cells via CD40 either by anti-CD40 mAbs, or 
the CD40L expressed as a cell surface molecule, can induce 
B cell proliferation and Ig synthesis.  However, the signals 
provided by the activated T cells do not seem to be confined 
to  the  CD40L-CD40  interaction  since:  (a)  non-IL-4- 
producing T cells could directly induce germline e transcripts 
in B cells, whereas anti-CD40 mAb cannot (4, 5);  (b) the 
anti-CD40-mediated IgE production is not susceptible to the 
1 Abbreviations  used  in  this paper: CD40L,  CD40  ligand;  mTNF-o~, 
transmembrane  form of TNF-c~. 
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cytokines strongly abrogate IgE responses induced by T cell 
clones (2);  (c)  the anti-CD40 mAb and the T  cell clones 
strongly synergize in the induction of IgE, IgG4, total IgG, 
and IgM synthesis (13); and (d) isotype switching can be in- 
duced by hydrocortisone or  EBV  in  the presence  of IL-4 
(16,  17). 
Based on these observations, we speculated that T cell ac- 
tivation-induced molecules other than CD40L may play a 
role in T-B cell interactions required for IL-4-dependent Ig 
synthesis. Kriegler et al. (22) have shown that TNF-ol is ex- 
pressed as a cell surface transmembrane protein of 26 kD on 
activated human monocytes or murine cells transfected with 
the human TNF-c~ gene. Subsequently, Kinkhabwala et al. 
(23)  have shown that the transmembrane form of TNF-oL 
(mTNF-c~) is also expressed  on normal activated human T 
cells. In addition, a TNF-c~-related  transmembrane molecule 
is expressed  on murine T  cells (24). 
In this report we demonstrate that the 26-kD mTNF-c~ 
expressed  on activated CD4 + T  cell clones provides  a co- 
stimulatory signal required for IL-4-dependent Ig produc- 
tion induding IgG4 and IgE synthesis by B cells, mAbs against 
both the mTNF-ot and the p55 TNF receptor (TNFR) in- 
hibited Ig production, indicating that in addition to CD40L- 
CD40 signaling, interactions between mTNF-o~ and its puta- 
tive ligand, the p55 TNFR, are involved in induction of B 
cell activation by activated CD4 § Th cells. 
Materials and Methods 
Cells.  Highly purified  B cells were isolated  from normal spleens 
obtained from patients undergoing splenectomy due to trauma. 
Splenocytes  were obtained by aseptically  squashing spleens through 
a sterile metal mesh. The splenocytes  were then washed twice in 
medium and frozen in aliquots for subsequent use. When needed, 
splenocytes were thawed, washed twice in Yssel's medium, and 
stained for 30 min on ice with the following PE-conjugated  mAbs: 
anti-CD3, anti-CD4, anti-CD8, anti-CD14, anti-CD16, and anti- 
CD56 (Becton Dickinson & Co., San Jose, CA). The cells were 
then washed once in medium, centrifuged over Histopaque 1077 
(Sigma Chemical  Co., St. Louis,  MO) density gradient, and washed 
twice in PBS. The stained splenocytes  were then negatively sorted 
with a FACStar Plus  |  (Becton Dickinson & Co.). An aliquot of 
the sorted cells was reanalyzed  by FACS  |  after staining with CD20- 
FITC (anti-Leu-16)  or isotype control mAb. The sorted cells were 
always >98% CD20 +  . In other experiments sIgD + B cells were 
obtained by two-color sorting of splenocytes labded for negative 
sorting as above, followed by anti-hIgD-FITC mAb (Nordic, Til- 
burg, The Netherlands). slgD + cells were obtained by sorting the 
PE-negative and FITC-positive cells. Reanalysis  of the sorted cells 
showed that they were >99.5%  sIgD +. 
The CD4 + TCR c~/B  + T cell clone B21 (Th0), which is spe- 
cific for tetanus toxoid, the non-IL-4-secreting T cell done SF-A3, 
which is specific for HLA-DR4 (25), and HY06 (Thl) (26) were 
grown in Yssel's medium containing 1% heat-inactivated human 
serum and were used for coculture with B cells 4-6 d after res- 
timulation with irradiated feeder cells and PHA, or for immuno- 
precipitation of mTNF-c~ as described in a following section. 
Preparation ofT Celt Membranes.  Plasma  membranes were pre- 
pared according to Brian (27) and Maeda et al. (28) from the T 
cell clones B21 and SP-A3. Briefly,  B21 and SP-A3 ceils were har- 
vested 12-15 d after they had been activated  by feeder  cells and PHA, 
washed once in medium, and resuspended in Yssel's medium sup- 
plemented with 10% FCS and 10/zg/ml Con A (Sigma Chemical 
Co.) at 5  x  106 cells/ml. After 8-12 h of culture, the Con A in 
the culture was neutralized with 4 mg/ml c~-methyl-D-mannoside, 
and 30 min later the cells were harvested, washed three times in 
PBS, resuspended at  5  x  106 cells/ml in cold homogenization 
buffer, and processed as described (27, 28). The plasma membranes 
were resuspended at 500 #g/ml (which is equivalent to '~2  x  l0  s 
cells/ml) and stored under liquid nitrogen. 
Reagents.  The following anti-TNF-c~ mAbs were used: 1825.12 
(IgG1) and 6401.1 (IgG1), which recognize mTNF-o~, were both 
kind gifts of  Dr. Harvey  Gaylord  (R&D Systems,  Minneapolis,  MI). 
mAb 63-29 (IgG1) was a kind gift of Dr. R. Torensma (U-Gene 
Research, University of Utrecht,  The Netherlands). anti-human 
TNF-c~ mAb was purchased from UBI (Lake Placid, NY).  The 
anti-TNF-c~-FITC mAb Fluorokine  TM kit for cytofluorometric  anal- 
)'sis was purchased from R&D Systems and the IgG1-FITC con- 
trol mAb was from Becton Dickinson & Co. Polyclonal  anti-human 
TNF-c~ was purchased from R&D Systems. The anti-TNF-ot mAb 
CRTS was a kind gift of  Dr. Wydenes (Centre de Recherche  Tram- 
fusion, Sanguine  Besan~on,  France). mAbs htr-9 and utr-1, directed 
to the p55 and p75 TNF receptors, respectively (29), were kind 
gifts of Dr. M. Brockhaus (Hoffman-La Roche, Basel, Switzer- 
land). The hybridoma line producing the anti-CD40 mAb 89 (30) 
was a kind gift of Dr. J. Banchereau (Schering-Plough France, 
Dardilly, France). The mAb PDV5.2 directed against a framework 
determinant of human class II MHC molecules  was kindly provided 
by Dr. H. Bruning (University  Hospital, Leiden,  The Netherlands). 
The anti-CD4 mAb RPA-T4 has been clustered in the IV Interna- 
tional Workshop on Human Leukocyte Differentiation Antigens 
(31). The anti-CD4 mAb RIV-7 was kindly provided by Dr. H. 
Kreeftenberg (Ryks Institut voor de Volksgerondheid, Bilthoven, 
The Netherlands). mAb 25D2.11, specific for human IL-4, was 
kindly provided  by Dr. J. Abrams (DNAX Research Institute, Palo 
Alto, CA). The hybridoma line producing the control mAb OX-8 
specific for rat CD8 was a kind gift of  Dr. Alan Williams (Medical 
Research Council, Oxford,  UK). All mAbs used for functional 
studies were in purified form, sterile, and diluted in PBS. rIL-4, 
IFN-c~, and IFN-3' were provided by Schering-Plough Research 
(Bloomfield, NJ). 
Culture Conditions.  5,000 highly purified B cells were cocul- 
tured with an equal number of T cell clones B21 or SP-A3, which 
were harvested 4-6 d after stimulation with feeder cells and PHA, 
in a final volume of 0.2 ml of Yssel's medium supplemented with 
10% FCS, 10 #g/ml ultra pure transferrin (Pierce Chemical Co., 
Rockford, IL), and 400 U/ml rlL-4, as described (13). Cultures 
were set up in six to eight replicates  in U-bottomed 96-well Linbro 
plates (Flow Laboratories  Inc., McLean,  VA) and incubated 12-14 d 
at 37~  in 5% CO2. At the end of the incubation period, the 
supernatants from each of the six to eight wells were harvested 
and pooled for isotype determination. In another series of experi- 
ments, the T cell clones were replaced by 5/~g of plasma mem- 
branes derived  from the T cell  clones, or by the anti-CD40 mAb 89. 
Isotype Determination.  Ig isotype production was determined 
by ELISA as previously described (2, 32). The sensitivities of the 
ELISA were determined with calibrated standards from Behring 
(Marburg, Germany), and found to be 0.2 ng/ml for IgE and IgG4, 
and 0.5-1 ng/ml for total IgG and IgM. 
Radioiodination, Immunoprecipitation, and SDS-PAGE.  B21 and 
HY06 cells were harvested 14 d after addition of feeder  cells, washed 
once, and resuspended at 3  x  106 cells/ml in Yssd's medium con- 
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(TPA) (Calbiochem-Behring  Corp., La Jolla, CA), and 500 ng/ml 
A23187 calcium  ionophore (Calbiochem-Behring  Corp.). After 7 
h of culture, the cells were  harvested, washed three times in PBS 
containing 10 -6 M KI, and iodinated with 12sI with lactoperoxi- 
dase-catalyzed  reaction  as previously  described  by Meuer  et al. (33). 
After iodination, the calls were washed five times with cold PBS 
containing 0.02% NaN3 and lysed  on ice for 30 rain in lysis buffer 
(1% NP-40, 50 mM Tris, 150 mM NaC1, 20 kU/ml aprotinin, 
1 mM PMSF). The nuclei were removed  by centrifugation, and 
the lysate was precleared  three times (twice for I h and once over- 
night) with Pansorbin  TM cells (Calbiochem-Behring  Corp.) pelleted 
from 200/~1 10% suspension, precoated  with rabbit anti-mouse 
Ig (Pel-Freez  Biologicals, Rodgers, AR). Immunoprecipitation  of 
radiolabeled  surface  proteins  was carried  out by incubation  for 2.5 h 
at 4~  of each 100 #1 of lysate with Pansorbin  TM cells precoated 
with: rabbit anti-mouse Ig and mAbs 1825.12 and 6401.1, or rabbit 
anti-mouse Ig as control. The coated  Pansorbin  TM cells were  washed 
six times in stringent wash buffer (lysis  buffer containing 1% so- 
dium deoxycholate)  and boiled for 3 min in sample  buffer  containing 
2-ME as reducing agent. The Pansorbin  TM cells were removed  by 
centrifugation and the samples  were run in a 15% polyacrylamide 
gel (Integrated Separation Systems, Natick, MA) under reducing 
conditions at 200 V. After staining with Coomassie  blue and des- 
taining (50 and 5% methanol solutions, 7.5% glacial acetic acid), 
the gels were dried and autoradiographed  using a Kodak  X-Omatic 
AR5 film, in a cassette  (Wolf  X-Ray  Corporation, New York, NY) 
mounted  with  a  Cronex Lightening Plus intensifying screen 
(DuPont Co., Wilmington, DE). 
Results 
Anti-TNF-oz or Anti-p55  TNFR mAbs Inhibit Ig Synthesis 
Induced by T Cell Clones.  Addition of anti-human TNF-ot 
mAbs to cultures of  highly purified, negatively sorted B cells 
or sIgD + B cells cocultured with activated CD4 + human 
T call dones inhibited IL-4-induced Ig production (Table 1). 
The various anti-TNF-ot mAbs had differential inhibitory 
effects. The mAbs 1825.12 and 6401.1 were most effective 
(Table 1) and were selected  for subsequent studies. Anti-TNF-oz 
mAbs  effectively inhibited  IgG4  and  IgE  production by 
purified B cells, but ordy moderate or weak inhibition of total 
IgG production was observed, whereas IgM production was 
generally not affected in these cultures.  However, the anti- 
TNF-ee mAbs inhibited IgM, total IgG, IgG4, and IgE syn- 
thesis induced in cultures of slgD + B cells (Table 1, exp. 3). 
In addition,  the mAb htr-9,  which recognizes the p55 
TNFR, strongly inhibited IgG4 and IgE, and to a lesser ex- 
tent total IgG, IgM, production in cocultures of slgD + B 
calls, and the T cell clone B21 (Table 1, exp. 3). In contrast, 
mAb utr-1, which recognizes the p75 TNFR, had no in- 
hibitory effects (Table 1, exp. 3). As reported previously (6), 
anti-class II MHC and anti-CD4 mAbs inhibited the produc- 
tion of all isotypes. 
Taken together these results indicate that anti-TNF-cr mAbs 
inhibit to variable extents IL-4-induced  Ig production, in- 
cluding IgG4 and IgE synthesis in cultures of slgD + B cells 
or total B cells, although the inhibitory effects on IgG and 
particularly IgM production in the latter cultures were gener- 
ally much weaker. 
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Anti-TNF-oz  mAbs Block Membrane-induced Ig Synthesis. 
The CD4 + Th clones used in these studies produce soluble 
TNF-oe  after  activation  (Yssel, H.,  R.  de Waal Malefyt, 
J. E. de Vries, unpublished  results).  Since the anti-TNF-c~ 
mAbs also block the biological activity of solnhle TNF-ot, 
we replaced the intact activated CD4 + T cell clones by their 
plasma membranes to exclude that the inhibitory effect ob- 
served with anti-TNF-ce mAb was due to the neutralization 
of soluble TNF-oz released  by the activated T cell done. Anti- 
TNF-ee mAb inhibited Ig responses induced by membranes 
from B21 T cell done (Tables 2 and 3), as well as the non-IL- 
4-producing clone SP-A3 (Table 2). The level of inhibition 
of IgG4 and IgE synthesis by mAb 1825.12 was in the same 
range as that obtained by an anti-IL-4 mAb, whereas mAb 
6401.1 was less efl~dent in blocking IgG4 and IgE synthesis 
(Table 2). 
Anti-TNF-ot mAbs also had considerable inhibitory effects 
on IgM and total IgG synthesis in these cultures, confirming 
the notion that mTNF-ce is not only involved in T-B cell 
interactions  resulting in switching to IgG4 and IgE syn- 
thesis, but also block the interaction  of activated CD4 + T 
cell clones or their membranes and IgM- or IgG-committed 
B cells. Preincubation  of the T cell membranes with anti- 
TNF-oz mAbs significantly decreased the ability of the mem- 
branes to provide the costimulatory signals required for the 
induction oflg synthesis, including IgG4 and IgE synthesis. 
Total IgG and IgM production was again affected to a lesser 
extent than IgG4 and IgE production (Table 3). 
Anti-TNF-oe mA bs Are Not Inhibitory  for CD40-induced IgG4 
andlgE Synthesis.  The results above suggest that anti-TNF-c~ 
mAbs act at the T cell level, but it is well established that 
TNF-ot also can act on B cells. We have previously shown 
that TNF-ot enhances IL-4-dependent  IgE production and 
germline ~ transcription  in B cells (5). In addition,  TNF-c~ 
produced by polyclonally activated B cells has been shown 
to be involved in B cell differentiation and IgG secretion in 
an autocrine fashion (34). Furthermore, IgG secretion by ton- 
sillar B cells stimulated with Staphylococcus aureus cells and 
I1.-2 were partially inhibited by polyclonal goat anti-human 
TNF-ot (34). To determine whether the anti-TNF-ot mAbs 
acted on B cells, these mAbs were tested in a T cell-free cul- 
ture system, using soluble anti-CD40 mAb and IL-4 to stimu- 
late highly purified B cells as described previously (13). In 
Table 4 it is shown that Ig production, including IgG4 and 
IgE, was not inhibited by anti-TNF-ot mAbs, further sup- 
porting the hypothesis that the inhibition by anti-TNF-ot 
mAb is at the T  cell level. 
Activated T Cell Clones Rapidly Express mTNF-cr after Acti- 
vation.  A previous report has shown expression of mTNF-~ 
on normal peripheral blood T cells after activation with TPA 
and ionomycin (23). After our observation that anti-TNF-ot 
mAbs could abrogate IgE synthesis induced by activated T 
call clones or their plasma membranes, we tested the T cell 
clones used in these experiments for surface TNF-ce expres- 
sion. The T cell clones were stimulated  with Con A, and 
mTNF-oz expression was measured at various time intervals 
by staining the ceils with the Fluorokine  TM kit FITC-labeled 
anti-TNF-c~ mAb, which binds to mTNF-c~. The kinetics Table  1.  Effect  of Anti-TNF-ce mAbs on Ig Synthesis Induced by an Activated T  Cell Clone and IL-4 
Exp.  IgM  IgG  IgG4  IgE 
B  <1  2  _+  1  <0.2  <0.2 
B  +  IL-4  +  B21  123  +  28  232  _+  51  93  +  15  97  +_  4 
+  Control mAb  109  +  55  205  +  36  81  +  5  90  +_  3 
+  Anti-TNF-cr 63.29  137  +  117  261  _+  47  69  +  7  46  _+  13 
+  Anti-TNF-c~ 1825.12  134  +  43  208  _+  22  24  _+  15  <0.2 
+  Anti-TNF-c~ 6401.1  127  +  33  198  _+  63  37  _+  17  31  _+  11 
+  Anti-TNF-ot DNAX  156  +  31  217  _+  82  51  _+  3  32  +_  4 
+  Anti-TNF-c~ CRTS  236  _+  90  222  +_  51  112  _+  35  72  +  6 
+  Anti-TNF-c~ UBI  152  __  87  248  +_  83  72  +  8  51  +  5 
+  Anti-TNF-~ polyd.  214  +_  76  233  +_  38  129  +  24  46  +  2 
+  Anti-class II  <1  <0.2  <0.2  <0.2 
+  Anti-CD4 (RIV-7)  41  +  9  23  _+  4  6  +  1  7  +  3 
B  2  _+  0  12  _+  1  1  _+  1  <0.2 
B  +  IL-4  5  _+  2  14  _+  1  1  +  0  <0.2 
B  +  IL-4  +  B21  286  _+  99  1,765  _+  62  1,268  +  309  63  +_  15 
+  Control mAb  195  _+  32  1,965  +  145  1,182  +  219  70  +  20 
+  anti-TNF-cr 63.29  266  +  38  1,891  _+  122  885  +  63  39  +  7 
+  anti-TNF-c~  1825.12  212  _  33  1,044  +_  33  324  _+  18  3  +_  1 
+  Anti-TNF-cr 6401.1  232  _+  28  1,694  _+  45  825  _+  36  28  _+  7 
+  Anti-TNF-ce UBI  291  +_  65  1,866  +_  50  1,220  +  94  50  +  1 
+  Anti-TNF-a polycl.  268  +_  33  1,916  _+  218  1,310  +_  211  26  +  2 
slgD +  11  +  3  17  _+  2  <0.2  <0.2 
slgD +  +  B21  11  +  2  14  _+  5  <0.2  <0.2 
slgD §  +  IL-4  +  B21  143  _+  20  499  +  33  42  +  6  15  +  4 
+  Control mAb  132  +_  13  478  _+  95  39  +  4  13  +  3 
+  Anti-TNF-R utr-1  131  +_  7  459  _+  42  56  _+  8  21  +  4 
+  Anti-TNF-R htr-9  90  _+  10  178  +_  33  6  _+  0  5  +  1 
+  Anti-TNF-c~ 1825.12  87  _+  26  32  +  10  2  +_  1  <0.2 
+  Anti-TNF-c~ 6401.1  88  _+  10  111  _+  11  <0.2  2  +_  0 
Highly purified B cells (exps. 1 and 2) or slgD + B cells (exp. 3) were cultured in the presence of B21 T cells and IL-4. Highly purified negatively 
sorted B cells (>98% CD20 +) or sorted slgD  + B cells (>99.5% slgD  +) from normal spleens were cocultured for 12-14 d with an equal number 
of B21 cells, 400 U/rot IL-4, and mAbs as indicated. All mAbs were added at the beginning of the culture at a concentration of 10/~g/ml.  The 
supernatants from eight replicates were pooled and assayed for Ig isotype content by ELISA. Values represent means and standard deviations  of tripli- 
cate wells of the ELISA. 
of mTNF-c~ expression on T cell clone B21 are shown in Fig. 
1. Induction  of mTNF-c~ was observed already 2 h after stim- 
ulation. By 8 h  100% of the cells expressed mTNF-o~. Peak 
expression was obtained between 24 and 36 h,  after which 
mTNF-a expression decreased gradually (Fig. 1). Similar results 
were obtained with two other CD4 § T  cell clones known 
to induce Ig synthesis by B cells in the presence of IL-4 (data 
not shown). 
Expression of mTNF-cr on T  Celt Clones Is Not Affected by 
IFN-'y or IFN-cr.  IFN-'y and IFN-o~ have been shown to 
block IgE synthesis induced by activated T cells but not that 
induced by anti-CD40 mAbs (3, 13, 14), suggesting that these 
cytokines may interfere with costimulatory T cell signals. We 
therefore tested whether IFN-'y and IFN-c~ mediate their ac- 
tion by preventing mTNF-ol expression on T  cell clones. In 
Fig.  2  it  is  shown that  IFN-3' and IFN-ot did not  affect 
mTNF-ot expression, even when the T cell clones were prein- 
cubated with these cytokines for 24 h before Con A  activa- 
tion. This suggests that IFN-3' and IFN-c~ modulate IL-4- 
dependent IgE synthesis independently from mTNF-c~ ex- 
pression. 
Immunoprecipitation and SDS-PAGE of  Radiolabeled TNF-c~ 
from Activated B21  T  Cell Clone.  Immunochemical studies 
have indicated that mTNP-~x has a molecular mass of 26 kD 
1578  Membrane  TNF-c~ as Costimulatory Signal for Ig Synthesis Table  2.  Effect  of Anti-TNF-cr mAbs on Ig Synthesis Induced by T  Cell Membranes and IL4 
Exp.  IgM  IgG  IgG4  IgE 
1  B  <1  10_+  3  1_+0  <0.2 
B  +  B21  membranes  14  +  0  76  _+  47  2  _+  0  <0.2 
B  +  B21membranes  +  IL-4  145  +  62  178_+  28  12  +  3  82  +  24 
+  Control mAb  184  +  55  199  _+  35  10  +_  4  89  _+  34 
+  Anti-TNF-c~ 1825.12  35  _+  6  64  _+  18  <1  6  _+  2 
+  Anti-TNF-cx 6401.1  75  +  18  90  _+  24  5  +  2  35  _+  14 
+  Anti-ID4  7_+  4  18_+  10  1_+  0  2_+  0 
+  Anti-CD4  (Riv-7)  25  +  3  69  _+  31  <0.2  <0.2 
+  Anti-CD4  (1LPA-T4)  21  +  7  23  _+  1  1 _+ 0  <0.2 
+  Anti-class  II MHC  7  +  3  11  +_  1  5  _+  2  <0.2 
2  B  <1  <1  <0.2  <0.2 
B  +  A3  membranes  11  +  1  68  +  17  <0.2  <0.2 
B  +  ILo4  +  A3 membranes  183  _+  31  306  _+  53  204  _+  23  151  +  13 
+  Control mAb  150  _+  23  296  _+  41  193  +  11  145  _+  17 
+  Anti-TNF-a  1825.12  6  _+  1  <1  <0.2  <0.2 
+  Anti-TNF-o~ 6401.1  93  _+  25  175  _+ 40  107  _+  2  73  +_  8 
3  B  <1  <I  <0.2  <0.2 
B  +  IL-4  +  A3  membrane  61  _+  5  338  +_  60  222  _+  21  88  _+  20 
+  Control  mAb  59  +  5  340  _+  49  254  _+  34  131  _+  48 
+  Anti-TNF-c~  1825.12  5  _+  1  5  _+  1  <0.2  <0.2 
+  Anti-TNF-cx 6401.1  25  +  1  190  +_  42  60  _+  17  37  _+  17 
Ig synthesis by highly purified B cells in the presence of plasma membranes  of B21 of SP-A3 T cells and IL-4 is blocked by anti-TNP-cx mAbs. Highly 
purified B cells were cocultured with 10/~g/ml plasma membranes  of Con A-activated B21 or A3 cells with or without 400 U/ml IIr  and mAbs 
as indicated.  The supernatants  from each of six or eight replicate cultures in exps. 2 and 3 were pooled and then assayed by ELISA in triplicate  wells. 
The cultures  in exp.  1 were set up in triplicate  and  assayed individually  by ELISA. 
Table  3.  Effect  of Pretreatment of T  Cell Membranes with Anti-TNF-ot  mAbs on Ig Synthesis 
IgM  IgG  IgG4  IgE 
B 
B  +  B21  membranes 
B  +  Ib4  +  B21  membranes 
+  Control  mAb 
+  Anti-TNF-cx 1825.12 
+  Anti-TNF-ol 6401.1 
Membranes  pretreated  with  control  mAb 
Membranes  pretreated  with  anti-TNF-o~  1825.12 
Membranes  pretreated  with  anti-TNF-c~ 6401.1 
<1  <1  3  -+  1  <0.2 
3-+  1  27  +_  17  4  +_  1  <0.2 
15_+  8  316_+  53  62_+  10  18_+  5 
20_+  12  335_+  41  57_+  7  20  +  7 
1  _+  1  <1  <0.2  <0.2 
10_+  2  46_+19  21_+3  5_+  1 
9  +  2  252+_37  59_+  10  12+1 
1_+1  21_+2  6+_1  1+_0 
2_+  0  78  +  9  <0.2  1_+  0 
Inhibition of B21 membrane-induced IgE synthesis by anti-TNFct  mAb and pretreatment of the membranes  with anti-TNF-c~ mAbs.  Plasma mem- 
branes from Con A-activated B21 cells were pretreated  for 2 h with the indicated mAbs, washed three times, and resuspended in the original volume 
of medium. 5,000 highly purified B cells were cocultured with 2/zg of membranes  in each of eight wells. II..4 (400 U/m1) and mAbs were added 
to some of the cultures  as indicated.  The supernatants  from eight wells were pooled after  14 d of culture and assayed for Ig content by ELISA. The 
standard  deviation  is of triplicate  wells  of the ELISA.  One of two experiments  shown. 
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Exp.  IgM  IgG  IgG4  IgE 
1  B  1  __  1  2  _+  1  <0.2  <0.2 
B  +  IL-4  1  _+  1  2  _+  1  <0.2  <0.2 
B  +  IL-4  +  otCD40  13  _+  2  310  _+ 45  139  _+  23  77 _+  1 
+  Control mAb  10  _+  2  275  _+  56  146  +  35  89  _+  8 
+  Anti-TNF-c~ 6401.1  10  _+  0  281  _+  47  122  _+  40  59  +_  5 
+  Anti-TNF-o~ 1825.1  14  +  1  228  _+  25  138  _+  13  53  _+  9 
2  B  2_+  1  3+2  1-+0  <0.2 
B  +  IL-4  2  _+  0  4  +  1  1  -+  3  <0.2 
B  +  IL-4  +  ~CD40  21  -+  5  267  -+  12  109  _+  15  56  _+  9 
+  Control mAb  18  _+  1  319  _+  44  122  +  2  76  _+  7 
+  Anti-TNF-~ 6401.1  16  _+  2  275  _+  37  110  _+  17  54  __.  4 
+  Anti-TNF-c~ 1825.12  14  -+  2  330  _+  21  132  +  23  62  -+  7 
3  B  <1  1 _+  0  <0.2  <0.2 
B  +  IL-4  +  ~CD40  11  _+ 3  48_+  3  21  _+  1  10-+  2 
+  Control mAb  12  -+  3  54  -+  1  27  -+  3  9  _+  1 
+  Anti-TNF-c~ 6401.1  10  _+  2  40  _+  1  21  _+  4  13  __.  2 
+  Anti-TNF-~ 1825.12  12  _+  2  46  _+  1  23  _+  5  9  _+  1 
Effect of anti-TNF-ot  mAbs on Ig synthesis induced in highly purified B cells by the anti-CD40 mAb 89 and IL-4. Highly purified negatively  sorted 
B cells (>98% CD20  §  were cultured in the presence of 400 U/ml IL-4 and 10 #g/ml mAb 89, specific  for human CD40. The indicated mAbs 
were added at the beginning of the culture, and 12-14 d later the supernatants were assayed for Ig concentration  by ELISA. The values represent 
means and standard deviations of triplicate wells of the ELISA. 
(22, 23). To determine whether the anti-TNF-c~ mAbs used 
in our studies reacted with the 26-kD transmembrane TNF-~ 
molecule, TNF-ot was immunoprecipitated from two acti- 
vated T cell clones, B21 (Th0) and HY06 (Thl). Fig. 3 shows 
that mAbs 1825.12 and 6401.1 precipitated two peptides of 
26 and 17 kD from the surface of radiolabeled activated B21 
and HY06 cells. These bands were absent from the control 
lanes. These results confirm the FACS  |  analysis and indicate 
that the 26-kD mTNF-ot is indeed expressed on activated B21 
CD4 + T cell clones, as described for peripheral blood T cells 
after activation (23). In addition, these results indicate that 
the 26-kD TNF-ot is present as an integral transmembrane 
molecule on activated T  cell clones. The immunoprecipita- 
tion of the 17-kD form of TNF-ot, in addition to the 26-kD 
transmembrane TNF-ot, is consistent with a previous report 
showing precipitation of both TNF-ot forms from the sur- 
face of mouse 3T3 cells transfected with the human TNF-ot 
gene (22). 
Discussion 
IL-4 directs IgE switching in B cells (1, 2), but additional 
costimulatory signals  are required for productive IgE syn- 
thesis.  These signals  can be delivered by activated CD4 + T 
cell clones, but not by resting CD4 + nor by activated CD8 + 
T cell clones (6). One such a costimulatory signal is provided 
by the CD40L, which has been recently cloned in mice (18) 
and humans  (19-21). 
Herein we show that the mTNF-ot on activated CD4 § T 
cells is another costimulatory signal for IL-4-dependent Ig 
production by B cells. Membrane TNF-ot is rapidly expressed 
on CD4 + T cell clones after activation. All T cell clones ex- 
pressed this molecule 8 h after activation, mAbs that bind 
mTNF-ot inhibited predominantly IgG4 and IgE synthesis 
and to a lesser  extent total IgG production in cultures of 
purified B  cells,  activated CD4 +  T  cell clones,  and IL-4. 
IgM production in these cultures was generally not affected 
by anti-TNF-o~ mAbs.  However, in  cultures of slgD +  B 
ceils production of IgM,  total IgG, IgG4, and IgE was in- 
hibited, suggesting that inhibition of the interactions between 
mTNF-oe and its ligand not only interfered with the signaling 
pathways required for IL-4-induced IgG4 and IgE switching, 
but also with productive T-B cell interactions resulting in 
IgM and total IgG production. The differential inhibitory 
effects of anti-TNF-c~ mAbs in cultures of total B cells versus 
slgD + B cells are presently difficult to explain, but they may 
be related to differences in the relative contribution of  mTNF-o~ 
and other T  cell surface molecules (such as the CD40L) to 
activation of naive slgD + B cells or total B cells.  The ex- 
periments in which membranes of activated CD4 + T  cell 
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Figure 1.  Kinetics  of surface  TNF-(~ expres- 
sion by the CD4 + T cell clone  B21 activated 
with Con A. Resting  B21 cells (12 d after  last 
stimulation with feeder  cells and PHA) were 
cultured  in Yssel's  medium  supplemented  with 
10% FCS and 10/~g/ml Con A. At the indi- 
cated time intervals, aliquots  of cells were har- 
vested, washed  twice  in PBS, and stained  with 
the following  FITC-labeled  antibodies: mouse 
IgG1 control (/eft), anti-human  mTNF-o~  (m/d- 
dle),  or the positive control anti-CD69 mAb 
(right).  The cells were then washed  and fixed 
in 1% paraformaldehyde.  At the end of the 
48-h period, all samples were analyzed  by a 
FACScan  |  flow cytometer. 
clones were used indicated that mTNF-c~ is also involved in 
the interaction between activated CD4 + T  cell clones and 
IgM- or IgG-committed B cells. Anti-TNF-oL mAbs blocked 
the production of all isotypes in these cultures. 
Anti-TNF-ol mAbs did not block Ig production induced 
by anti-CD40 mAbs and IL-4 in the absence ofT cells, indi- 
cating that inhibition occurred at the Th cell and not at the 
B cell level.  In addition, the observation that anti-TNF-o~ 
mAbs effectively blocked Ig production in cultures where 
intact CD4 + T  cell  clones were replaced  by their plasma 
membranes is compatible with the idea that mTNF-ol ex- 
pressed on activated CD4 + T cell clones, rather than soluble 
TNF-tx, produced by the T cell clones, was the target of the 
anti-TNF-c~ mAbs. This notion was further supported by 
the finding that pretreatment of the T cell plasma membranes 
with anti-TNF-(x mAbs decreased  their capacity to induce 
B cells to produce Ig. 
The expression of mTNF-ot on activated T cell clones was 
confirmed by immunoprecipitation of the 26-kD  form of 
TNF-oe, from the surface of radiolabeled T cell clones. These 
results are in agreement with other studies, which showed 
that this 26-kD polypeptide represented mTNF-o~ on mono- 
cytes, mouse cells transfected with the human TNF-(x gene 
(22), and activated peripheral blood T cells (23). In addition, 
a distinct band of 17 kD was detected. This protein probably 
represents the mature form of  TNF-c~, since it has been shown 
that in addition to the 26-kD molecule, peptides of 17 kD 
representing the mature form of TNF-c~ could be immuno- 
precipitated from surface-labeled 3T3 cells, transfected with 
the human TNF-c~ gene (22). In contrast to the 26-kD mol- 
ecule, the 17-kD band was not detected in immunoprecipi- 
tates from activated T cells (23). However, in the latter assays, 
a protein with a molecular mass of 50-60 kD, which was 
suggested to represent the trimeric TNF-c~  molecule, was 
detected (23). The possibility that TNF-n, trimers bound to 
TNFRs on T  cells could be responsible for delivering the 
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Figure 2.  Effect  of IFN-y and IFN-o~  prett~atment 
of B21 T cell clones on the expression of mTNF-~ 
after Con A stimulation.  Resting (12 d after last stim- 
ulation with feeder  cells  and PHA) B21 cells  were  cul- 
tured at 106 cells/ml  in Yssel's  medium  containing  1% 
human serum and 100 U/ml IFN-3,  or IFN-~, or left 
untreated. After 24 h the cells  were harvested,  washed 
twice in PBS, and resuspended  in the original  volume 
of Yssel's medium containing 5/~g/ml Con A. Some 
cells were  left untreated  throughout the culture  period 
(first row). 24 h later, the cultures were harvested, 
washed twice in RDF1 buffer (R&D Systems), and 
stained for 1 h with FITC-labeled  anti-TNF-~ mAb 
(Fluorokine  TM kit; R&D Systems), mouse IgG1 iso- 
type control (Becton  Dickinson  & Co.), or anti-CD69 
mAbs. After washing in RDF1 buffer the cells were 
analyzed  with a FACScan  |  flow  cytometer.  The FACS  | 
profile from cells treated only with  Con  A  (not 
pretreated with cytokines),  stained  with anti-TNF-ot 
mAb (middle,  second row), was superimposed on the 
histograms of IFN-'y- and  IFN-ot-pretreated cells 
stained with anti-TNF-ot  mAb (middle, third and  fourth 
rows, respectively). 
costimulatory signal to B cells seems remote, since it would 
imply that TNF-o~ binding sites on TNFRs on T  cells are 
different from those on B cells.  To date such information is 
not available. Furthermore, pretreatment of the activated T 
Figure  3.  Immunoprecipitation  of  mTNF-ot. Call lysates  from radiola- 
beled B21 (lanes  A and B) and HY06 (lanes C and D) cells, activated  with 
TPA plus A23187 calcium ionophore, were used to immunoprecipitate 
mTNF-a with Pansorbin" cells  precoated  with rabbit anti-mouse Ig and 
mAbs 1825.12 and 6410.1 (lanes A and D).  Lanes B and C are from 
immunoprecipitates  using rabbit anti-mouse  Ig-coated  Pansorbin  TM as con- 
trois. Immunoprecipitated  proteins were run on a 15% polyacrylamide 
mini-gd under reducing  conditions.  The dried gds were autoradiographed 
by exposing to Kodak x-ray films for 32 h. 
cell clone B21  with  a low pH  glycine buffer,  a  treatment 
known to dissociate soluble ligands from their receptors (35), 
caused no significant decrease in anti-TNF-ct mAb binding 
to these cells, as judged by FACS  |  analysis, while it readily 
removed FITC-labeled anti-CD4 mAb from precoated B21 
cells used as controls  (data not  shown). 
It has been suggested that the diversity of physiological 
actions mediated by TNF-ct may be a result of the differen- 
tial actions of the soluble versus the transmembrane forms 
of TNF-cr (36). In addition, it has been reported that mTNF-ct 
and soluble TNF-ot can mediate distinct biological functions. 
For example,  in vivo regression of some murine tumors is 
mediated  by  soluble,  and  not  by  mTNF-o~  (37),  whereas 
mTNF-ot on activated T cells, in contrast to soluble TNF-ot, 
can trigger antileishmanial defense in macrophages by direct 
cell-cell contact (38, 39).  It is therefore not surprising that 
in our  studies  the mTNF-ot expressed on activated CD4 § 
T  cell clones, rather than the secreted cytokine, is involved 
in T-B cell interactions required for B cell activation and in- 
duction of Ig synthesis. 
The mTNF-ot is a type II glycoprotein (22) similar to the 
CD40L  (18,  21).  In addition,  more recently,  sequence ho- 
mologies in the receptor-binding portion of the extracellular 
domains  between  both  murine  TNF-ot  and  the  murine 
CD40L,  and human TNF-ot and the human CD40L,  have 
been reported (20, 40), suggesting a functional similarity be- 
tween mTNF-ot and CD40L. The CD40 molecule is a member 
of the TNF receptor/nerve growth factor receptor family (41). 
Since CD40L-CD40  interactions result in B cell activation 
(18-21),  the  present  data  indicating  that  interactions  of 
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in B cells activation was not unexpected. The ligand(s) for 
mTNF-c~ are not known,  although  the most likely candi- 
dates are the two forms of TNFRs. Resting peripheral B cells 
express both forms of TNFRs in low amounts, and after ac- 
tivation the p75 TNFR is upregulated (42). Both forms of 
TNFRs  can mediate  signal  transduction  (43,  44).  In  our 
studies, the mAb htr-9,  which recognizes the p55 TNFR, 
inhibited  Ig synthesis in slgD + cells  stimulated with acti- 
vated T cell clones and IL-4. This observation, together with 
the finding  that  anti-TNF-o~ mAb inhibits  Ig synthesis at 
the T  cell level,  suggests that  the p55 TNFR is a possible 
ligand for the mTNF-ol expressed on activated T cell clones. 
It also suggests that this mAb binds to an epitope involved 
in the functional interaction between the mTNF-cz on T cells 
and the p55 TNFR on B cells. The finding that the anti-p75 
TNFR mAb utr-1 had no inhibitory effects on IL-4-dependent 
Ig synthesis implies that either the p75 TNFR is not a func- 
tional ligand for mTNF-o~, or that this mAb binds to an epi- 
tope on  the p75  TNFR  that  does not  interfere  with  the 
binding  of the mTNF-c~. 
IFN-'y and IFN-ot are known to inhibit IgE synthesis when 
B cells are stimulated by T cell clones, but not by anti-CD40 
mAbs (13,  14). These observations suggest that the inhibi- 
tory action of these cytokines is mediated via the costimula- 
tory signals delivered by T cells. In our present studies, incu- 
bation of the T  cell clones with IFN-7 and IFN-c~ did not 
prevent expression of mTNF-o~,  indicating  that  these cyto- 
kines do not inhibit IgE synthesis by modulating mTNF-a 
expression. 
The finding that mTNF-c~ is involved in noncognate T-B 
cell interactions adds to the complexity of both the pleiotropic 
effects of this cytokine, and the mechanisms  of T  cell-in- 
duced B cell activation and differentiation.  In addition, our 
data indicate that  multiple  T  cell surface molecules play a 
role in T-B cell interactions  resulting  in Ig production. 
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